MDS to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
01 Febbraio 2007 - 2:00PM
PR Newswire (US)
TORONTO, Feb. 1 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE:
MDZ), a leading provider of products and services to the global
life sciences markets, announced today that Stephen P. DeFalco,
President and Chief Executive Officer, will present at the Merrill
Lynch Global Pharmaceutical, Biotechnology and Medical Device
Conference in New York City on Thursday, February 8, at 1:40 pm
Eastern Standard Time. Interested parties may access the live
webcast by visiting the "Latest News" section of the MDS home page
at http://www.mdsinc.com/ and clicking on the conference link. An
audio archive and the presentation slides will also be available
after the event on the "Webcasts & Presentations" page in our
"For Investors" section of the MDS website. MDS Inc. is a global
life sciences company that provides market-leading products and
services that our customers need for the development of drugs and
the diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 8,800 highly skilled people in 28 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers,
Vice-President, Investor Relations and External Communications,
(416) 675-6777, ext. 34721,
Copyright